medigraphic.com
Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán

2019, Número 5

<< Anterior Siguiente >>

Rev Invest Clin 2019; 71 (5)


A Multivariate Prognostic Score for Predicting Mortality of Acquired Immunodeficiency Syndrome Patients with Hypoxemic Respiratory Failure and Pneumocystis jiroveci Pneumonia

Hernández-Cárdenas CM, Mendoza-Copa G, Hong-Zhu P, Gómez-García IA, Lugo-Goytia G

Idioma: Ingles.
Referencias bibliográficas: 39
Paginas: 311-320
Archivo PDF: 213.54 Kb.


RESUMEN

Sin resumen.


REFERENCIAS (EN ESTE ARTÍCULO)

  1. Joint United Nations Programme on HIV and AIDS (UNAIDS). Mexico. Available From: http://www.unaids.org/es/regionscountries/ countries/mexico. [Last accessed on 2018 Oct 06].

  2. Vincent B, Timsit JF, Auburtin M, et al. Characteristics and outcomes of HIV-infected patients in the ICU: impact of the highly active antiretroviral treatment era. Intensive Care Med. 2004; 30:859-66.

  3. Powell J, Davis JL, Morris AM, et al. Survival for patients with human immunodeficiency virus admitted to the intensive care unit continues to improve in the current era of highly active antiretroviral therapy. Chest. 2009;135:11-17.

  4. Wachter RM, Luce JM, Turner J, Volberding P, Hopewell PC. Intensive care of patients with the acquired immunodeficiency syndrome. Outcome and changing patterns of utilization. Am Rev Respir Dis. 1986;134:891-6.

  5. Montaner JS, Hawley PH, Ronco JJ, et al. Multisystem organ failure predicts mortality of ICU patients with acute respiratory failure secondary to AIDS-related PCP. Chest. 1992;102:1823- 8.

  6. Speich R, Opravil M, Weber R, et al. Prospective evaluation of a prognostic score for Pneumocystis carinii pneumonia in HIV-infected patients. Chest. 1992;102:1045-8.

  7. Huang L, Quartin A, Jones D, Havlir DV. Intensive care of patients with HIV infection. N Engl J Med. 2006;355:173-81.

  8. Coquet I, Pavie J, Palmer P, et al. Survival trends in critically ill HIV-infected patients in the highly active antiretroviral therapy era. Crit Care. 2010;14:R107.

  9. Fisk DT, Meshnick S, Kazanjian PH. Pneumocystis carinii pneumonia in patients in the developing world who have acquired immunodeficiency syndrome. Clin Infect Dis. 2003;36:70-8.

  10. Billings JD, Davey DL, Konda KA, et al. Factors associated with previously undiagnosed human immunodeficiency virus infec tion in a population of men who have sex with men and maleto- female transgender women in Lima, Peru. Medicine (Baltimore). 2016;95:e5147.

  11. Collins GS, Reitsma JB, Altman DG, Moons KG. Transparent reporting of a multivariable prediction model for individual prognosis or diagnosis (TRIPOD): the TRIPOD statement. BMJ 2015; 350:g7594.

  12. Mehta RL, Kellum JA, Shah SV, et al. Acute kidney injury network: report of an initiative to improve outcomes in acute kidney injury. Crit Care. 2007;11:R31.

  13. Vincent JL, Moreno R, Takala J, et al. The SOFA (Sepsis-related organ failure assessment) score to describe organ dysfunction/ failure. On behalf of the working group on sepsis-related problems of the European society of intensive care medicine. Intensive Care Med. 1996;22:707-10.

  14. Ferguson ND, Fan E, Camporota L, et al. The berlin definition of ARDS: an expanded rationale, justification, and supplementary material. Intensive Care Med. 2012;38:1573-82.

  15. Marshall A, Altman DG, Holder RL, Royston P. Combining estimates of interest in prognostic modelling studies after multiple imputation: current practice and guidelines. BMC Med Res Methodol. 2009;9:57.

  16. Vesin A, Azoulay E, Ruckly S, et al. Reporting and handling missing values in clinical studies in intensive care units. Intensive Care Med. 2013;39:1396-404.

  17. Collett D. Modelling Binary Data. 2nd ed. New York: Chapman and Hall/CRC; 2003.

  18. Sullivan LM, Massaro JM, D’Agostino RB Sr. Presentation of multivariate data for clinical use: the Framingham study risk score functions. Stat Med. 2004;23:1631-60.

  19. Miller ME, Langefeld CD, Tierney WM, Hui SL, McDonald CJ. Validation of probabilistic predictions. Med Decis Making. 1993; 13:49-58.

  20. Nagelkerke NJ. A note on a general definition of the coefficient of determination. Biometrika 1991;78:691-692.

  21. Hanley JA, McNeil BJ. The meaning and use of the area under a receiver operating characteristic (ROC) curve. Radiology. 1982; 143:29-36.

  22. Van Calster B, Nieboer D, Vergouwe Y, et al. A calibration hierarchy for risk models was defined: from Utopia to empirical data. J Clin Epidemiol. 2016;74:167-76.

  23. Steyerberg EW, Harrell FE Jr., Borsboom GJ, et al. Internal validation of predictive models: efficiency of some procedures for logistic regression analysis. J Clin Epidemiol. 2001;54:774-81.

  24. Peduzzi P, Concato J, Kemper E, Holford TR, Feinstein AR. A simulation study of the number of events per variable in logistic regression analysis. J Clin Epidemiol. 1996;49:1373-9.

  25. Box GE, Tidwell PW. Transformation of the independent variables. Technometrics. 1962;4:531-550.

  26. Hosmer DW Jr., Lemeshow S, Sturdivant RX. Applied Logistic Regression. 3rd ed. Hoboken, NJ: Wiley; 2013.

  27. Garrouste-Orgeas M, Troche G, Azoulay E, et al. Body mass index. An additional prognostic factor in ICU patients. Intensive Care Med. 2004;30:437-43.

  28. Mangili A, Murman DH, Zampini AM, Wanke CA. Nutrition and HIV infection: review of weight loss and wasting in the era of highly active antiretroviral therapy from the nutrition for healthy living cohort. Clin Infect Dis. 2006;42:836-42.

  29. Yatabe T, Yamashita K, Yokoyama M. Lower body mass index is associated with hospital mortality in critically ill Japanese patients. Asia Pac J Clin Nutr. 2016;25:534-7.

  30. Pickkers P, de Keizer N, Dusseljee J, et al. Body mass index is associated with hospital mortality in critically ill patients: an observational cohort study. Crit Care Med. 2013;41:1878-83.

  31. Zampieri FG, Colombari F. A gradient-boosted model analysis of the impact of body mass index on the short-term outcomes of critically ill medical patients. Rev Bras Ter Intensiva. 2015; 27:141-8.

  32. Melchior JC, Salmon D, Rigaud D, et al. Resting energy expenditure is increased in stable, malnourished HIV-infected patients. Am J Clin Nutr. 1991;53:437-41.

  33. Shikuma CM, Zackin R, Sattler F, et al. Changes in weight and lean body mass during highly active antiretroviral therapy. Clin Infect Dis. 2004;39:1223-30.

  34. Ronit A, Sharma S, Baker JV, et al. Serum albumin as a prognostic marker for serious non-AIDS endpoints in the strategic timing of antiretroviral treatment (START) study. J Infect Dis. 2018;217:405-12.

  35. Taverna M, Marie AL, Mira JP, Guidet B. Specific antioxidant properties of human serum albumin. Ann Intensive Care. 2013;3:4.

  36. Di Napoli M, Behrouz R, Topel CH, et al. Hypoalbuminemia, systemic inflammatory response syndrome, and functional outcome in intracerebral hemorrhage. J Crit Care. 2017;41:247-53.

  37. Barbier F, Coquet I, Legriel S, et al. Etiologies and outcome of acute respiratory failure in HIV-infected patients. Intensive Care Med. 2009;35:1678-86.

  38. Miller RF, Allen E, Copas A, Singer M, Edwards SG. Improved survival for HIV infected patients with severe Pneumocystis jirovecii pneumonia is independent of highly active antiretroviral therapy. Thorax. 2006;61:716-21.

  39. Davis JL, Morris A, Kallet RH, et al. Low tidal volume ventilation is associated with reduced mortality in HIV-infected patients with acute lung injury. Thorax. 2008;63:988-93.




2020     |     www.medigraphic.com